BARCLAYS PLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 49 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3
-25.0%
2,6680.0%0.00%
Q2 2023$40.0%2,6680.0%0.00%
Q1 2023$40.0%2,668
-3.0%
0.00%
Q4 2022$4
-100.0%
2,751
-43.2%
0.00%
Q3 2022$20,000
+100.0%
4,844
+81.6%
0.00%
Q2 2022$10,000
-75.6%
2,668
-68.8%
0.00%
Q1 2022$41,0008,5540.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders